NOVARTIS AG (NVSEF)
Clinical trial NCT07504783: status: ACTIVE_NOT_RECRUITING → COMPLETED.
Clinical trial NCT07504783: status: ACTIVE_NOT_RECRUITING → COMPLETED.
Clinical trial NCT05000021 updates: 1. status: RECRUITING → ACTIVE_NOT_RECRUITING 2. completion date: 2026-06-01 → 2027-07-01 3. primary completion date: 2026-06-01 → 2026-10-01 4. enrollment: 93 → 96 participants 5. enrollment type: ESTIMATED → ACTUAL
Clinical trial NCT05653349: completion date: 2028-12-06 → 2029-01-05.
Clinical trial NCT07604974: start date: 2026-05-01 → 2026-05-12.
Clinical trial NCT04629547 updates: 1. completion date: 2026-05-01 → 2028-05-01 2. primary completion date: 2026-05-01 → 2028-05-01
Clinical trial NCT07549698 updates: 1. status: NOT_YET_RECRUITING → RECRUITING 2. start date: 2026-04-01 → 2026-06-01
Clinical trial NCT07592273: start date: 2026-05-20 → 2026-06-01.
Clinical trial NCT06844383: start date: 2026-05-01 → 2026-05-05.
Clinical trial NCT07240246 updates: 1. status: ACTIVE_NOT_RECRUITING → COMPLETED 2. completion date: 2026-05-11 → 2026-05-12 3. enrollment type: ESTIMATED → ACTUAL
Clinical trial NCT05565378 updates: 1. completion date: 2027-02-26 → 2027-12-06 2. primary completion date: 2027-02-26 → 2026-11-09